UCLA Health
At UCLA Health, we provide the best health care, using the latest medical technology — healing humankind one patient at a time.
ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposomal Irinotecan + 5-Fluorouracil/Leucovorin + Oxaliplatin (NALIRIFOX) vs. nab-Paclitaxel + Gemcitabine in Treatment-Naïve Patients With mPDAC
By
ASCO GI 2023 Conference Coverage
FEATURING
Zev A. Wainberg
By
ASCO GI 2023 Conference Coverage
FEATURING
Zev A. Wainberg
Login to view comments.
Click here to Login